webinar register page

Webinar banner
Sepsis Alliance Clinical Community Sponsor Innovation Day: The Role of a Host Response Test in Early Identification and Appropriate Intervention for Sepsis
Session presented by Immunexpress
In this webinar, Dr Roy Davis provides an overview of the current challenges of sepsis diagnosis and management, specifically related to early identification and appropriate intervention. He describes how the host immune response can be leveraged by including a gene expression assay as part of the Sepsis Clinical Toolset. The proposed role for this assay in the clinical workflow and sepsis program triage will be covered along with its impact on diagnostic uncertainty.

Mar 4, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Roy F. Davis, PhD, MD, MHA
Chief Medical Officer @Immunexpress
Dr Roy Davis, CMO at Immunexpress Inc., has 30 years’ experience in clinical medicine (Neonatal, Pediatric Critical Care) and hospital administration as Clinical Assistant Professor, WAMI program, Department of Pediatrics, University of Washington and as a Consultant in health care standards and quality of care delivered. While CMO at Providence Alaska he assisted in the implementation of MEWS and sepsis surveillance algorithms using the Microsoft Amalga platform across Providence Health & Services and won a national Microsoft Healthcare innovation award for work with MEWS in 2012. He has been with Immunexpress for 5 years, involved in the development and clinical validation of the role of host response in the diagnosis of sepsis